These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26117478)

  • 1. Home based care to multi-drug resistant tuberculosis patients: A pilot study.
    Vaghela JF; Kapoor SK; Kumar A; Dass RT; Khanna A; Bhatnagar AK
    Indian J Tuberc; 2015 Apr; 62(2):91-6. PubMed ID: 26117478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid profile status of patients treated for multidrug-resistant tuberculosis in state of Meghalaya, India.
    Saharia GK; Ruram AA; Lyngwa J
    Indian J Tuberc; 2015 Jul; 62(3):166-70. PubMed ID: 26600329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: A prospective study.
    Patel SV; Nimavat KB; Alpesh PB; Shukla LK; Shringarpure KS; Mehta KG; Joshi CC
    J Infect Public Health; 2016; 9(4):478-84. PubMed ID: 26724262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
    Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
    Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multi drug resistance tuberculosis in the field: Tuberculosis Research Centre experience.
    Thomas A; Ramachandran R; Rehaman F; Jaggarajamma K; Santha T; Selvakumar N; Krishnan N; Mohan NS; Sundaram V; Wares F; Narayanan PR
    Indian J Tuberc; 2007 Jul; 54(3):117-24. PubMed ID: 17886699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Category II anti-tuberculosis treatment in Indian children.
    Mukherjee A; Khandelwal D; Singla M; Lodha R; Kabra SK
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1153-7. PubMed ID: 26459525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
    Singla N; Singla R; Jain G; Habib L; Behera D
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
    Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
    PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of treatment interruptions among drug-sensitive and drug-resistant pulmonary tuberculosis patients - A study from South Delhi, New Delhi, India.
    Kumar L; Kumar S; Vohra V; Mohan K; Khayyam KU
    Indian J Tuberc; 2024; 71 Suppl 1():S72-S76. PubMed ID: 39067959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
    Bang D; Lillebaek T; Thomsen VØ; Andersen AB
    Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study.
    Thu MK; Kumar AMV; Soe KT; Saw S; Thein S; Mynit Z; Maung HMW; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):410-417. PubMed ID: 29351672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
    McNally TW; de Wildt G; Meza G; Wiskin CMD
    BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-optimization in the treatment of multidrug resistant tuberculosis in Nigeria.
    Musa BM; John D; Habib AG; Kuznik A
    Trop Med Int Health; 2016 Feb; 21(2):176-82. PubMed ID: 26610176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
    Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV.
    Furin J; Isaakidis P; Reid AJ; Kielmann K
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1479-84. PubMed ID: 25517815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
    J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.